Evidence map›Paper›PMID 40805859›Full record

ArticleHealthcare (Basel, Switzerland)2025

Evaluation of Pre-Treatment Assessment of Semaglutide Users: Balancing the Benefits of Weight Loss vs. Potential Health Consequences.

Faten F Bin Dayel, Rakan J Alanazi, Miteb A Alenazi, Sahar Alkhalifah, Mohammed Alfaifi, Sultan Alghadeer, Abdulrahman Alwhaibi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Faten F Bin DayelDepartment of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0009-0006-8181-8374
Rakan J AlanaziPharmacy Practice Department, College of Pharmacy, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0009-0000-1781-5191
Miteb A AlenaziDepartment of Pediatrics, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
Sahar AlkhalifahPharmacy Department, Imam Muhammad Ibn Saud Islamic University, Riyadh 13317, Saudi Arabia.
Mohammed AlfaifiCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Sultan AlghadeerDepartment of Clinical Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Abdulrahman AlwhaibiDepartment of Clinical Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-8519-3363

Funding

King Saud University, Riyadh, Saudi Arabia Researcher Supporting Project Number (RSPD-2025R572)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

assessmentdiseasehistorylaboratoryOzempic®screeningsemaglutide

Identifiers

PMID40805859
PMCPMC12346479

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.